Valley National Advisers’s Eli Lilly LLY Stock Holding History

Valley National Advisers’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.04M	Buy	5,036 +49	+1%	+$50.1K	0.67%	31
2026 Q1	$4.59M	Sell	4,987 -36	-0.7%	-$36.5K	0.59%	32
2025 Q4	$5.4M	Buy	5,023 +139	+3%	+$133K	0.75%	26
2025 Q3	$3.73M	Buy	4,884 +49	+1%	+$36.5K	0.58%	33
2025 Q2	$3.77M	Buy	4,835 +246	+5%	+$191K	0.62%	30
2025 Q1	$3.79M	Buy	4,589 +16	+0.3%	+$13.3K	0.68%	26
2024 Q4	$3.53M	Buy	4,573 +255	+6%	+$211K	0.63%	30
2024 Q3	$3.83M	Sell	4,318 -1,583	-27%	-$1.42M	0.69%	29
2024 Q2	$5.34M	Hold	5,901	–	–	0.79%	27
2024 Q1	$4.59M	Buy	5,901 +165	+3%	+$117K	0.69%	32
2023 Q4	$3.34M	Buy	5,736 +337	+6%	+$197K	0.53%	41
2023 Q3	$2.9M	Sell	5,399 -7	-0.1%	-$3.61K	0.51%	43
2023 Q2	$2.54M	Buy	5,406 +31	+0.6%	+$13K	0.43%	52
2023 Q1	$2.06M	Sell	5,375 -197	-4%	-$66.4K	0.36%	60
2022 Q4	$2.01M	Sell	5,572 -2,476	-31%	-$878K	0.36%	65
2022 Q3	$2.7M	Sell	8,048 -44	-0.5%	-$13.9K	0.56%	47
2022 Q2	$2.65M	Sell	8,092 -114	-1%	-$34.2K	0.56%	43
2022 Q1	$2.35M	Buy	8,206 +311	+4%	+$80K	0.45%	52
2021 Q4	$2.18M	Sell	7,895 -158	-2%	-$40.1K	0.4%	69
2021 Q3	$1.86M	Sell	8,053 -608	-7%	-$150K	0.34%	82
2021 Q2	$1.99M	Sell	8,661 -46	-0.5%	-$9.24K	0.36%	72
2021 Q1	$1.63M	Buy	8,707 +1,223	+16%	+$239K	0.32%	81
2020 Q4	$1.26M	Sell	7,484 -128	-2%	-$19.1K	0.27%	77
2020 Q3	$1.13M	Sell	7,612 -118	-2%	-$18.3K	0.26%	65
2020 Q2	$1.27M	Sell	7,730 -68	-0.9%	-$10.4K	0.29%	57
2020 Q1	$1.08M	Buy	7,798 +261	+3%	+$35.9K	0.3%	63
2019 Q4	$991K	Sell	7,537 -39	-0.5%	-$4.52K	0.25%	79
2019 Q3	$847K	Sell	7,576 -65	-0.9%	-$7.24K	0.23%	82
2019 Q2	$847K	Sell	7,641 -60	-0.8%	-$7.07K	0.23%	79
2019 Q1	$999K	Sell	7,701 -3,348	-30%	-$407K	0.29%	68
2018 Q4	$1.28M	Sell	11,049 -74	-0.7%	-$8.27K	0.42%	54
2018 Q3	$1.19M	Buy	11,123 +1	+0%	+$100	0.41%	57
2018 Q2	$949K	Sell	11,122 -199	-2%	-$16.3K	0.36%	63
2018 Q1	$876K	Sell	11,321 -15	-0.1%	-$1.21K	0.33%	68
2017 Q4	$957K	Sell	11,336 -76	-0.7%	-$6.47K	0.33%	61
2017 Q3	$976K	Sell	11,412 -1,388	-11%	-$114K	0.33%	55
2017 Q2	$1.05M	Sell	12,800 -621	-5%	-$50.7K	0.38%	49
2017 Q1	$1.13M	Sell	13,421 -5,081	-27%	-$407K	0.43%	46
2016 Q4	$1.36M	Sell	18,502 -96	-0.5%	-$7.15K	0.63%	47
2016 Q3	$1.49M	Buy	18,598 +1,439	+8%	+$115K	0.77%	39
2016 Q2	$1.35M	Buy	17,159 +1,600	+10%	+$120K	0.7%	44
2016 Q1	$1.12M	Sell	15,559 -126	-0.8%	-$9.53K	0.6%	51
2015 Q4	$1.32M	Buy	15,685 +17	+0.1%	+$1.41K	0.78%	39
2015 Q3	$1.31M	Sell	15,668 -262	-2%	-$22.1K	0.79%	42
2015 Q2	$1.33M	Hold	15,930	–	–	0.75%	39
2015 Q1	$1.16M	Buy	15,930 +287	+2%	+$20.4K	0.68%	46
2014 Q4	$798K	Buy	+15,643	New	+$1.06M	0.6%	44

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Valley National Advisers's LLY Position: Q2 2026 in Review

Valley National Advisers increased its Eli Lilly (LLY) stake by 0.98% in Q2 2026, buying an estimated $50.1K and bringing the position to 5,036 shares worth $6.04M. The position accounts for 0.67% of the portfolio, ranked #31.

Valley National Advisers first reported a position in LLY in Q4 2014 and has held it in 47 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Valley National Advisers held 5,036 shares of Eli Lilly worth $6.04M as of Q2 2026.
Valley National Advisers bought 49 Eli Lilly shares in Q2 2026, an estimated $50.1K.
Eli Lilly made up 0.67% of Valley National Advisers's portfolio in Q2 2026, its #31 holding.
Valley National Advisers first reported a position in Eli Lilly in Q4 2014 and has held it in 47 quarters since.
4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.